Product Information
TERBUTALINE SULFATE 2.5 MG TAB is a generic product labeled by Chartwell RX LLC, priced at $0.9467 per EA under NDC 62135052490. Its NADAC has been published 169 times since Jul 12, 2023.
FDA first approved this application on Mar 25, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Chartwell RX LLCNDC
62135052490
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TERBUTALINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA077152FDA Approved
3/25/2005
TE Code
AB
On Market Since
3/25/2005
Price Statistics
The NADAC for TERBUTALINE SULFATE 2.5 MG TAB has been published 169 times since Jul 12, 2023, and over the history we have for it it has declined 40.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9467 per EA |
|---|---|
| All-time high | $1.6000 (Apr 10, 2024) |
| All-time low | $0.8532 (Oct 23, 2024) |
| 52-week high | $1.1002 |
| 52-week low | $0.8931 |
| Median price | $1.0198 |
| Average price | $1.1452 |
| Largest weekly change | -38.5% (Apr 17, 2024) |
| Weeks tracked | 169 |
| Tracking since | Jul 12, 2023 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Terbutaline Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TERBUTALINE SULFATE 2.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for TERBUTALINE SULFATE 2.5 MG TAB, manufactured by Chartwell RX LLC, is $0.9467 per EA (NDC 62135052490), effective Sep 30, 2026.
How has the price of TERBUTALINE SULFATE 2.5 MG TAB changed over time?
Over the history we have for it, the NADAC for TERBUTALINE SULFATE 2.5 MG TAB has declined 40.8%. It has been tracked across 169 weekly CMS publications since Jul 12, 2023.
What are the highest and lowest recorded NADAC prices for TERBUTALINE SULFATE 2.5 MG TAB?
Since Jul 12, 2023, the NADAC for TERBUTALINE SULFATE 2.5 MG TAB has ranged from a low of $0.8532 (Oct 23, 2024) to a high of $1.6000 (Apr 10, 2024), with a median of $1.0198 per EA.
Are there cheaper alternatives to TERBUTALINE SULFATE 2.5 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TERBUTALINE SULFATE 2.5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures TERBUTALINE SULFATE 2.5 MG TAB?
TERBUTALINE SULFATE 2.5 MG TAB (NDC 62135052490) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.